110 related articles for article (PubMed ID: 3119892)
1. [A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP].
Maruyama M; Noda T; Kiyozuka Y; Okamura Y; Ibaraki T; Katou Y; Ninomiya Y; Oku M; Nabuchi K; Hino K
Gan No Rinsho; 1987 Oct; 33(12):1507-14. PubMed ID: 3119892
[TBL] [Abstract][Full Text] [Related]
2. [A case of curatively operated gastric cancer with peritonitis carcinomatosa treated by intraperitoneal administration of CDDP.Etoposide and EAP therapy].
Sakata Y; Okamura T; Kurimoto H; Ono K; Uenishi M
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2829-32. PubMed ID: 7993123
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer.
Fanning J; Hilgers RD
Gynecol Oncol; 1996 Dec; 63(3):323-7. PubMed ID: 8946866
[TBL] [Abstract][Full Text] [Related]
4. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644
[TBL] [Abstract][Full Text] [Related]
5. [A case of sacral neuroblastoma in an adult successfully treated with combination chemotherapy].
Marusawa H; Yamashita Y; Kajimura K; Kumegawa Y; Takaya H; Seto S; Fujisawa I; Hyakuna K; Kadota E
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1115-8. PubMed ID: 7611765
[TBL] [Abstract][Full Text] [Related]
6. [Cyclic high dose CAP therapy by short-stay admission for ovarian malignancies--to increase total dose of CDDP and to improve quality of life of patients].
Ochiai K; Isonishi S; Kimura E; Yokoyama S; Sasaki H; Arihiro T; Terashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan; 43(1):19-25. PubMed ID: 1997612
[TBL] [Abstract][Full Text] [Related]
7. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
8. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
[TBL] [Abstract][Full Text] [Related]
9. [A case of stage IVb ovarian carcinoma successfully treated with intra-arterial infusion chemotherapy using implantable reservoir system].
Kobayashi O; Kuwae C; Kohyama A; Yorinaga Y; Sudo H; Kitada H; Otsuka H; Minami T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1697-700. PubMed ID: 1530335
[TBL] [Abstract][Full Text] [Related]
10. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Mäenpää J; Kangas L; Grönroos M
Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.
Ueda Y; Sonoda Y; Fujiki H; Harada S; Kimura T; Itoh T; Imura K; Naito K; Nomura K; Taniwaki M; Yamagishi H
Oncol Rep; 2004 Aug; 12(2):323-32. PubMed ID: 15254697
[TBL] [Abstract][Full Text] [Related]
13. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
Inagaki J; Ogawa M; Horikoshi N; Ezaki K; Inoue K; Aiba K; Komyo M; Miyamoto H; Ikeda K; Kubo H
Gan No Rinsho; 1983 Aug; 29(10):1291-5. PubMed ID: 6685195
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
15. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
16. [A carcinosarcoma of the ovary: a case report and a review].
Ishihara H; Kanamori Y; Morishita K; Minagawa Y; Kigawa J; Matsui K
Gan No Rinsho; 1990 Sep; 36(11):2105-9. PubMed ID: 2232179
[TBL] [Abstract][Full Text] [Related]
17. [Experience with CDDP therapy in advanced and recurrent gastric cancer cases].
Tanemura H; Saji S; Takao H; Kida H; Kunieda K; Miya K; Azuma S; Furuta T; Sakata K; Shimokawa K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2951-5. PubMed ID: 3116948
[TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy with cisplatin and etoposide for cerebellar metastasis from ovarian adenocarcinoma].
Itoyama Y; Seto H; Kochi M; Kuratsu J; Korematsu K; Kitano I; Uemura S; Ushio Y
No Shinkei Geka; 1991 Aug; 19(8):751-4. PubMed ID: 1896120
[TBL] [Abstract][Full Text] [Related]
19. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
